*ST交投(002200.SZ):與關聯方簽訂共計1.25億元合同
格隆匯6月16日丨*ST交投(002200.SZ)公佈,爲實現公司業務訂單增量,改善公司持續經營能力,結合公司的經營範圍及工程施工優勢,公司參與了雲南交投集團公路建設有限公司(以下簡稱“公建公司”)對“宣威至會澤高速公路建築及沿線設施工程”和“勐孟高速公路項目建築沿線設施項目”的招標並中標。根據工作安排,公司將與公建公司簽訂上述兩個項目的專業分包合同,合同金額分別爲5,329萬元和7,133萬元,共計1.2462億元(具體以最終簽訂的合同所約定的金額爲準)。
公建公司爲公司控股股東雲南省交通投資建設集團有限公司的控股子公司,本次簽訂專業分包合同構成關聯交易,關聯交易金額爲1.2462億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.